Eidos Therapeutics
Why Robinhood?
You can watch EIDX and buy or sell other stocks, ETFs, and their options commission-free!About EIDX
Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR.
EIDX Key Statistics
Stock Snapshot
With a market cap of 4.75B, Eidos Therapeutics(EIDX) trades at $122.21. The stock has a price-to-earnings ratio of -46.10.
Eidos Therapeutics(EIDX) stock opened on 2026-03-03 at —. The price climbed to — and dipped to —.
Eidos Therapeutics(EIDX) shares are trading with a volume of 0, against a daily average of 138.46K.
During the past year, Eidos Therapeutics(EIDX) stock moved between $28.39 at its lowest and $132.54 at its peak.
During the past year, Eidos Therapeutics(EIDX) stock moved between $28.39 at its lowest and $132.54 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.